Isolation of Platelet-Derived Exosomes from Human Platelet-Rich Plasma: Biochemical and Morphological Characterization.

cytokines exosome markers growth factors human platelets platelet-derived-exosomes platelet-rich plasma

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
05 Mar 2022
Historique:
received: 31 01 2022
revised: 25 02 2022
accepted: 04 03 2022
entrez: 10 3 2022
pubmed: 11 3 2022
medline: 9 4 2022
Statut: epublish

Résumé

Platelet-Rich Plasma (PRP) is enriched in molecular messengers with restorative effects on altered tissue environments. Upon activation, platelets release a plethora of growth factors and cytokines, either in free form or encapsulated in exosomes, which have been proven to promote tissue repair and regeneration. Translational research on the potential of exosomes as a safe nanosystem for therapeutic cargo delivery requires standardizing exosome isolation methods along with their molecular and morphological characterization. With this aim, we isolated and characterized the exosomes released by human PRP platelets. Western blot analysis revealed that CaCl

Identifiants

pubmed: 35270001
pii: ijms23052861
doi: 10.3390/ijms23052861
pmc: PMC8911307
pii:
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Basque Government
ID : IT1230-19
Organisme : AlavaInnova
Organisme : Ministry of Economy, Industry and Competitiveness
ID : CTQ2017-85686-R
Organisme : Centro de Investigación Biomédica en Red de Salud Mental

Références

J Orthop Surg Res. 2019 Dec 30;14(1):470
pubmed: 31888697
J Biol Chem. 2017 Jun 16;292(24):10112-10122
pubmed: 28455445
J Transl Med. 2005 Feb 21;3(1):9
pubmed: 15723705
J Sex Med. 2011 Feb;8(2):437-46
pubmed: 21114767
Front Chem. 2017 Oct 31;5:89
pubmed: 29164105
J Orthop Res. 2020 Sep;38(9):1931-1941
pubmed: 32129513
Wound Repair Regen. 2008 Sep-Oct;16(5):585-601
pubmed: 19128254
Int J Mol Sci. 2021 Feb 09;22(4):
pubmed: 33572157
Eur J Endocrinol. 2014 Nov;171(5):641-8
pubmed: 25184282
Exp Cell Res. 2008 Jul 1;314(11-12):2176-86
pubmed: 18570917
Theranostics. 2017 Jan 15;7(3):733-750
pubmed: 28255363
Theranostics. 2017 Jan 1;7(1):81-96
pubmed: 28042318
Trends Biotechnol. 2017 Mar;35(3):192-202
pubmed: 28007307
Int J Pept. 2012;2012:532519
pubmed: 22518192
Curr Top Med Chem. 2013;13(2):164-79
pubmed: 23470076
Cytokine Growth Factor Rev. 2021 Dec 2;:
pubmed: 34924312
J Transl Med. 2005 Mar 02;3(1):10
pubmed: 15740633
Proteomics. 2009 Nov;9(21):4997-5000
pubmed: 19810033
J Neurochem. 2015 Mar;132(5):489-503
pubmed: 25308538
Clin Sports Med. 2019 Jan;38(1):17-44
pubmed: 30466721
Regen Ther. 2021 Mar 27;18:38-50
pubmed: 33869686
Nat Commun. 2021 Jul 19;12(1):4389
pubmed: 34282141
Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
pubmed: 18228490
Diabetes. 2004 Feb;53 Suppl 1:S12-8
pubmed: 14749260
Eur J Pain. 2022 Jan;26(1):43-60
pubmed: 34288258
Anal Chem. 2019 Oct 15;91(20):13297-13305
pubmed: 31549806
Injury. 2014 Oct;45 Suppl 4:S7-14
pubmed: 25384475
Cell Prolif. 2021 Dec;54(12):e13123
pubmed: 34609779
Cell Cycle. 2021 Aug;20(15):1487-1499
pubmed: 34229586
FASEB J. 2012 Jul;26(7):2811-23
pubmed: 22441986
Am J Pathol. 2015 Aug;185(8):2309-23
pubmed: 26073035
Cell Transplant. 2021 Jan-Dec;30:9636897211017833
pubmed: 34006140
J Nanobiotechnology. 2018 Oct 16;16(1):81
pubmed: 30326899
Front Cell Neurosci. 2014 Nov 10;8:377
pubmed: 25426026
Proteomes. 2019 Apr 28;7(2):
pubmed: 31035355
Neuropharmacology. 2001 Apr;40(5):686-95
pubmed: 11311896
Int J Mol Sci. 2016 Aug 24;17(9):
pubmed: 27563882
Blood. 1999 Dec 1;94(11):3791-9
pubmed: 10572093
ACS Biomater Sci Eng. 2019 Apr 8;5(4):1907-1919
pubmed: 33405564
Proc Natl Acad Sci U S A. 2016 Feb 23;113(8):E968-77
pubmed: 26858453
Calcif Tissue Int. 2004 Apr;74(4):313-6
pubmed: 15255066
Blood Rev. 1993 Mar;7(1):52-62
pubmed: 8467233
Expert Opin Biol Ther. 2017 Feb;17(2):197-212
pubmed: 27845852
Exp Neurol. 2021 Jul;341:113711
pubmed: 33785307
Am J Sports Med. 2020 Jul;48(9):2277-2286
pubmed: 32543878
Thromb Haemost. 1999 Dec;82(6):1730-5
pubmed: 10613662
Exp Eye Res. 2020 Apr;193:107973
pubmed: 32059976
Curr Pharm Des. 2017;23(40):6206-6214
pubmed: 28914201
Int J Mol Sci. 2020 Oct 21;21(20):
pubmed: 33096812
Eur Cell Mater. 2014 Sep 22;28:137-51; discussion 151
pubmed: 25241964
Mol Ther. 2008 Apr;16(4):782-90
pubmed: 18362931
Arthroscopy. 2012 Aug;28(8):1070-8
pubmed: 22840987
Annu Rev Pharmacol Toxicol. 2015;55:439-464
pubmed: 25292428
Molecules. 2021 Nov 16;26(22):
pubmed: 34833992
Transfusion. 2015 Mar;55(3):507-21
pubmed: 25332113
Expert Opin Biol Ther. 2020 Dec;20(12):1447-1460
pubmed: 32692595
Cells. 2019 Aug 08;8(8):
pubmed: 31398924
Front Bioeng Biotechnol. 2020 Mar 20;8:223
pubmed: 32266247
Front Genet. 2019 Aug 08;10:715
pubmed: 31440276
Trends Biotechnol. 2021 Jun;39(6):598-612
pubmed: 33160678
Cell J. 2021 Oct;23(5):576-583
pubmed: 34837686

Auteurs

Miquel Saumell-Esnaola (M)

Department of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.
Bioaraba, Neurofarmacología Celular y Molecular, 01008 Vitoria-Gasteiz, Spain.

Diego Delgado (D)

Advanced Biological Therapy Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.

Gontzal García Del Caño (G)

Bioaraba, Neurofarmacología Celular y Molecular, 01008 Vitoria-Gasteiz, Spain.
Department of Neurosciences, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.

Maider Beitia (M)

Advanced Biological Therapy Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.

Joan Sallés (J)

Department of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.
Bioaraba, Neurofarmacología Celular y Molecular, 01008 Vitoria-Gasteiz, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), 28029 Madrid, Spain.

Imanol González-Burguera (I)

Bioaraba, Neurofarmacología Celular y Molecular, 01008 Vitoria-Gasteiz, Spain.
Department of Neurosciences, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.

Pello Sánchez (P)

Advanced Biological Therapy Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.

Maider López de Jesús (M)

Department of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.
Bioaraba, Neurofarmacología Celular y Molecular, 01008 Vitoria-Gasteiz, Spain.

Sergio Barrondo (S)

Department of Pharmacology, Faculty of Pharmacy, University of the Basque Country UPV/EHU, 01006 Vitoria-Gasteiz, Spain.
Bioaraba, Neurofarmacología Celular y Molecular, 01008 Vitoria-Gasteiz, Spain.
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), 28029 Madrid, Spain.

Mikel Sánchez (M)

Advanced Biological Therapy Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.
Arthroscopic Surgery Unit, Hospital Vithas Vitoria, 01008 Vitoria-Gasteiz, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH